drugset / Trial / NCT01459796
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study was to determine the safety and tolerability of rilonacept for participants with gout who were initiating allopurinol.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rilonacept | Protein / enzyme biologic | 80 mg | Subcutaneous |
| Background | Allopurinol | Small molecule | 50 mg | Oral |
| Background | Allopurinol | Small molecule | 100 mg | Oral |